Neuroinflammatory conditions

Integrated Blood Inflammatory Ratios and Cerebrospinal Fluid Blood-Brain Barrier Dysfunction Predict Relapse Risk in Neuromyelitis Optica Spectrum Disorder

Study Overview The investigation centered on understanding the relationship between integrated blood inflammatory ratios and cerebrospinal fluid (CSF) blood-brain barrier […]

Integrated Blood Inflammatory Ratios and Cerebrospinal Fluid Blood-Brain Barrier Dysfunction Predict Relapse Risk in Neuromyelitis Optica Spectrum Disorder Read Post »

Ozanimod Reduces Serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP) and Modulates Innate and Adaptive Immunity in Patients with Low-to-Moderate Activity Relapsing-Remitting Multiple Sclerosis

Study Overview The research investigates the effects of ozanimod, an oral medication, on key biomarkers associated with neurodegeneration and inflammation

Ozanimod Reduces Serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP) and Modulates Innate and Adaptive Immunity in Patients with Low-to-Moderate Activity Relapsing-Remitting Multiple Sclerosis Read Post »

Scroll to Top